Bladder carcinoma (urothelial carcinoma)

1. introduction

Bladder carcinoma, also known as urothelial carcinoma, is one of the most common types of cancer of the urinary tract.
The Tumor develops mainly from the urothelial mucosa of the urinary bladder, which lines the inner wall.
Men are affected about three times as often as women.

Risk factors: Long-term smoking, contact with aromatic amines (e.g. in dyes), chronic bladder infections, radiotherapy, certain medications or long-term catheterization.

2. medical background

Bladder carcinoma develops from the urothelial cells of the bladder mucosa.
A distinction is made:

• Non-muscle-invasive carcinoma (NMIBC): limited to mucosa or submucosa,
• Muscle-invasive carcinoma (MIBC): Growth through the bladder wall, often aggressive course.

The most common histological type is transitional cell carcinoma, but squamous cell carcinoma and squamous cell carcinoma are also found. Adenocarcinomas before.

3. symptoms

Early symptoms are often unspecific.
Leading symptoms include:

• Blood in the urine (hematuria) - often the first warning sign
• Frequent urge to urinate and burning sensation when urinating
• Pain in the pelvic area
• In advanced stages: back pain, weight loss, fatigue

4. diagnostics

• Urinalysis (microscopy, tumor markers)
• Cystoscopy with Biopsy (gold standard)
• Ultrasound, CT, MRI to the stage classification
• Histopathological examination to differentiate the type of tumor

5. conventional medical therapy

Treatment depends on the stage and aggressiveness of the tumor:

• Transurethral resection (TUR-B) for superficial tumors
• Instillation therapy with BCG or mitomycin C
• Radical cystectomy for muscle-invasive carcinomas
• Chemotherapy or immunotherapy (e.g. PD-L1 inhibitors) in advanced stages

Regular aftercare is crucial, as relapses can occur frequently.

6. complementary approach: frequency therapy

The Frequency therapy is understood in complementary medicine as a supportive method that promotes energetic regulation and Cell communication is to promote.
The following frequencies are given for bladder carcinoma (urothelial carcinoma) (informative):

Here are the Frequency lists for bladder carcinoma (urothelial/transitional bladder carcinoma) from CAFL (Hz) and EDTFL/ETDFL (kHz):

CAFL (Hz)

• Cancer_bladder_TBC (transitional bladder carcinoma): 642, 771, 360, 726, 724.
• Cancer_bladder_secondary: Note in the list: „use Parasites, schistosoma“ (no separate block of numbers).

EDTFL / ETDFL (kHz)

Cancer: Urinary Bladder: 0.14, 0.32, 0.95, 5.25, 12.71, 45, 97.5, 150, 434.08, 985.67.

Cancer: Bladder Cancer: 0.13, 0.35, 47.5, 159.3, 352.93, 475.15, 527, 662.71, 742, 988.9.

7. conclusion

Bladder carcinoma is a common tumor disease that can have very good chances of recovery if diagnosed early.
A combination of conventional medicine and supportive procedures - such as diet, exercise, mental stability and frequency therapy - can improve general well-being and increase therapy tolerance.

⚠️ Disclaimer on frequency therapy

Frequency therapy is a complementary procedure whose effectiveness has not been scientifically proven.
It does not replace a medical examination, diagnosis or treatment.
All frequencies and notes mentioned here are for general information only. Information and must not be understood as a promise of salvation.
Patients should always consult qualified doctors or therapists before using alternative methods or changing treatments.